Stefania Giuliano1, Serafina Talarico1, Lucia Bruno1, Francesco Beniamino Nicoletti1,2, Claudio Ceccotti1,2, Antonino Belfiore3. 1. Department of Health Sciences, Endocrinology, University Magna Graecia of Catanzaro, Campus Universitario, Viale Europa, Località Germaneto, 88100, Catanzaro, Italy. 2. Neurosurgery Unit, Pugliese-Ciaccio Hospital, Catanzaro, Italy. 3. Department of Health Sciences, Endocrinology, University Magna Graecia of Catanzaro, Campus Universitario, Viale Europa, Località Germaneto, 88100, Catanzaro, Italy. belfiore@unicz.it.
Abstract
PURPOSE: Traumatic brain injury is considered the main cause of hypopituitarism in adults, and GH deficiency appears to be the most frequent pituitary deficit. Most of the available studies have included all degrees of severity of trauma. We aimed to assess pituitary function and GH deficiency in adult patients at different time lengths after complicated mild TBI according to Glasgow Coma Scale. We also aimed to evaluate whether mild TBI patients with GH deficiency had developed alterations in the glycolipid profile. METHODS: Forty-eight patients (34 men and 14 women) with complicated mild TBI were included in the study. Twenty-three patients were evaluated at 1 year (Group A) and 25 patients at 5 years or longer after the injury (Group B). All patients underwent basal hormonal evaluation for pituitary function. GH deficiency was investigated by the combined test (GH releasing hormone + arginine). The glycolipid profile was also evaluated. RESULTS: GH deficiency occurred in 8/23 patients (34.7 %) of Group A and in 12/25 patients (48 %) of Group B. In addition, two patients, one in each group, showed evidence of central hypothyroidism. Patients with GH deficiency, especially in Group A, presented a higher frequency of visceral adiposity and adverse metabolic profile as compared to no-GH deficiency patients. CONCLUSIONS: Patients examined at 1 year or several years from complicated mild TBI had a similarly high occurrence of isolated GH deficiency, which was associated with visceral adiposity and metabolic alterations. Our findings suggest that patients undergone complicated mild TBI should be evaluated for GH deficiency even after several years from trauma.
PURPOSE:Traumatic brain injury is considered the main cause of hypopituitarism in adults, and GH deficiency appears to be the most frequent pituitary deficit. Most of the available studies have included all degrees of severity of trauma. We aimed to assess pituitary function and GH deficiency in adult patients at different time lengths after complicated mild TBI according to Glasgow Coma Scale. We also aimed to evaluate whether mild TBIpatients with GH deficiency had developed alterations in the glycolipid profile. METHODS: Forty-eight patients (34 men and 14 women) with complicated mild TBI were included in the study. Twenty-three patients were evaluated at 1 year (Group A) and 25 patients at 5 years or longer after the injury (Group B). All patients underwent basal hormonal evaluation for pituitary function. GH deficiency was investigated by the combined test (GH releasing hormone + arginine). The glycolipid profile was also evaluated. RESULTS:GH deficiency occurred in 8/23 patients (34.7 %) of Group A and in 12/25 patients (48 %) of Group B. In addition, two patients, one in each group, showed evidence of central hypothyroidism. Patients with GH deficiency, especially in Group A, presented a higher frequency of visceral adiposity and adverse metabolic profile as compared to no-GH deficiencypatients. CONCLUSIONS:Patients examined at 1 year or several years from complicated mild TBI had a similarly high occurrence of isolated GH deficiency, which was associated with visceral adiposity and metabolic alterations. Our findings suggest that patients undergone complicated mild TBI should be evaluated for GH deficiency even after several years from trauma.
Authors: Kevin C J Yuen; Nicholas A Tritos; Susan L Samson; Andrew R Hoffman; Laurence Katznelson Journal: Endocr Pract Date: 2016-07-13 Impact factor: 3.443
Authors: Agatha A van der Klaauw; Nienke R Biermasz; Edith J M Feskens; Marieke B Bos; Johannes W A Smit; Ferdinand Roelfsema; Eleonora P M Corssmit; Hanno Pijl; Johannes A Romijn; Alberto M Pereira Journal: Eur J Endocrinol Date: 2007-04 Impact factor: 6.664
Authors: F Kelestimur; F Tanriverdi; H Atmaca; K Unluhizarci; A Selcuklu; F F Casanueva Journal: J Endocrinol Invest Date: 2004-12 Impact factor: 4.256
Authors: Nieke E Kokshoorn; Moniek J E Wassenaar; Nienke R Biermasz; Ferdinand Roelfsema; Johannes W A Smit; Johannes A Romijn; Alberto M Pereira Journal: Eur J Endocrinol Date: 2009-09-25 Impact factor: 6.664
Authors: Jasmeet P Hayes; Meghan E Pierce; Kate E Valerio; Mark W Miller; Bertrand Russell Huber; Catherine B Fortier; Jennifer R Fonda; William Milberg; Regina McGlinchey Journal: Neuropsychopharmacology Date: 2021-08-16 Impact factor: 8.294
Authors: Traver Wright; Randall Urban; William Durham; E Lichar Dillon; Kathleen M Randolph; Christopher Danesi; Charles Gilkison; Christof Karmonik; Dennis J Zgaljardic; Brent Masel; James Bishop; Richard Pyles; Rachael Seidler; Ashton H Hierholzer; Melinda Sheffield-Moore Journal: J Neurotrauma Date: 2020-01-17 Impact factor: 5.269